vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and STONERIDGE INC (SRI). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $205.2M, roughly 1.9× STONERIDGE INC).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Stoneridge Inc is a global designer and manufacturer of advanced electrical and electronic components, integrated systems, and sensor solutions. It serves automotive, commercial vehicle, off-highway, and aerospace sectors, delivering products that boost vehicle safety, efficiency, connectivity, and environmental performance across key global markets.
GRDN vs SRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $205.2M |
| Net Profit | $20.9M | — |
| Gross Margin | 21.5% | 16.2% |
| Operating Margin | 7.7% | -14.4% |
| Net Margin | 5.3% | — |
| Revenue YoY | — | -6.0% |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $-2.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | $205.2M | ||
| Q3 25 | $377.4M | $210.3M | ||
| Q2 25 | $344.3M | $228.0M | ||
| Q1 25 | $329.3M | $217.9M | ||
| Q4 24 | — | $218.2M | ||
| Q3 24 | $314.4M | $213.8M | ||
| Q2 24 | — | $237.1M | ||
| Q1 24 | — | $239.2M |
| Q4 25 | $20.9M | — | ||
| Q3 25 | $9.8M | $-9.4M | ||
| Q2 25 | $9.0M | $-9.4M | ||
| Q1 25 | $9.4M | $-7.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-122.0M | $-7.1M | ||
| Q2 24 | — | $2.8M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | 21.5% | 16.2% | ||
| Q3 25 | 19.8% | 20.3% | ||
| Q2 25 | 19.8% | 21.5% | ||
| Q1 25 | 19.5% | 21.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | 19.4% | 20.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 20.2% |
| Q4 25 | 7.7% | -14.4% | ||
| Q3 25 | 4.3% | -1.6% | ||
| Q2 25 | 3.7% | -1.1% | ||
| Q1 25 | 3.9% | -1.5% | ||
| Q4 24 | — | -2.0% | ||
| Q3 24 | -33.3% | 0.1% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 5.3% | — | ||
| Q3 25 | 2.6% | -4.5% | ||
| Q2 25 | 2.6% | -4.1% | ||
| Q1 25 | 2.9% | -3.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | -3.3% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | -2.6% |
| Q4 25 | — | $-2.76 | ||
| Q3 25 | — | $-0.34 | ||
| Q2 25 | — | $-0.34 | ||
| Q1 25 | — | $-0.26 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | — | $-0.26 | ||
| Q2 24 | — | $0.10 | ||
| Q1 24 | — | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $66.3M |
| Total DebtLower is stronger | $0 | $180.9M |
| Stockholders' EquityBook value | $217.9M | $179.8M |
| Total Assets | $412.7M | $551.2M |
| Debt / EquityLower = less leverage | 0.00× | 1.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $66.3M | ||
| Q3 25 | $36.5M | $54.0M | ||
| Q2 25 | $18.8M | $49.8M | ||
| Q1 25 | $14.0M | $79.1M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | $37.2M | $54.1M | ||
| Q2 24 | — | $42.1M | ||
| Q1 24 | — | $48.4M |
| Q4 25 | $0 | $180.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $201.6M | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $217.9M | $179.8M | ||
| Q3 25 | $195.5M | $251.2M | ||
| Q2 25 | $179.7M | $260.5M | ||
| Q1 25 | $163.2M | $253.1M | ||
| Q4 24 | — | $245.3M | ||
| Q3 24 | $133.9M | $271.4M | ||
| Q2 24 | — | $270.5M | ||
| Q1 24 | — | $277.3M |
| Q4 25 | $412.7M | $551.2M | ||
| Q3 25 | $390.0M | $632.1M | ||
| Q2 25 | $356.3M | $639.4M | ||
| Q1 25 | $334.0M | $657.4M | ||
| Q4 24 | — | $621.6M | ||
| Q3 24 | $348.0M | $662.5M | ||
| Q2 24 | — | $666.7M | ||
| Q1 24 | — | $675.4M |
| Q4 25 | 0.00× | 1.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.82× | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $8.8M |
| Free Cash FlowOCF − Capex | — | $2.6M |
| FCF MarginFCF / Revenue | — | 1.3% |
| Capex IntensityCapex / Revenue | — | 3.0% |
| Cash ConversionOCF / Net Profit | 1.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $12.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | $8.8M | ||
| Q3 25 | $28.2M | $3.6M | ||
| Q2 25 | $19.9M | $10.7M | ||
| Q1 25 | $17.6M | $10.9M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | — | $10.8M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | — | $9.1M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | $24.2M | $-2.7M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | — | 1.3% | ||
| Q3 25 | 6.4% | -1.3% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 6.4% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | 1.1% | 3.0% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.11× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
